12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Friday. Cyclerion Therapeutics, CNS Pharma, Longeveron, iSpecimen, Scinai Immunotherapeutics, and Disc Medicine saw notable gains, while Nexalin Technology, Kyverna Therapeutics, Gain Therapeutics, IN8bio, Nanoviricides, and Rezolute experienced significant declines.
June 14, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CNS Pharma stock rose 35.86% to $4.92, with a market cap of $1.9 million.
The substantial price increase suggests positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Cyclerion Therapeutics shares surged by 37.4% to $2.9, with a market cap of $7.2 million.
The significant price increase indicates strong investor interest or positive news, likely leading to short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Disc Medicine shares increased by 17.59% to $46.05, with a market cap of $1.1 billion.
The significant price increase suggests strong investor interest or positive news, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
iSpecimen stock moved upwards by 19.44% to $0.49, with a market cap of $4.8 million.
The significant price increase suggests positive sentiment, likely leading to short-term gains.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Longeveron shares moved upwards by 23.23% to $3.31, with a market cap of $21.0 million.
The notable price increase indicates positive investor sentiment, likely leading to short-term upward movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Scinai Immunotherapeutics stock rose 17.8% to $3.32, with a market cap of $1.9 million.
The price increase indicates positive investor sentiment, likely leading to short-term upward movement.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Gain Therapeutics shares fell 32.29% to $1.28, with a market cap of $23.1 million.
The significant price decline indicates negative sentiment, likely leading to short-term downward movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
IN8bio shares declined by 30.06% to $1.18, with a market cap of $51.8 million.
The notable price decline suggests negative sentiment, likely leading to short-term losses.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Kyverna Therapeutics shares decreased by 34.46% to $9.46, with a market cap of $408.0 million.
The substantial price decline suggests negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Nanoviricides shares declined by 25.39% to $1.93, with a market cap of $22.7 million.
The significant price decline indicates negative sentiment, likely leading to short-term downward movement.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Nexalin Technology stock fell 36.2% to $0.88, with a market cap of $6.5 million.
The significant price decline indicates negative sentiment or news, likely leading to short-term downward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Rezolute stock declined by 21.9% to $4.03, with a market cap of $161.7 million.
The notable price decline suggests negative sentiment, likely leading to short-term losses.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 100